Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United Kingdom healthcare workers. The first vaccine dos...

Full description

Bibliographic Details
Main Authors:	Payne, RP, Longet, S, Austin, JA, Skelly, DT, Dejnirattisai, W, Adele, S, Meardon, N, Faustini, S, Al-Taei, S, Moore, SC, Tipton, T, Hering, LM, Angyal, A, Brown, R, Nicols, AR, Gillson, N, Dobson, SL, Amini, A, Supasa, P, Cross, A, Bridges-Webb, A, Reyes, LS, Linder, A, Sandhar, G, Kilby, JA, Tyerman, JK, Altmann, T, Hornsby, H, Whitham, R, Phillips, E, Malone, T, Hargreaves, A, Shields, A, Saei, A, Foulkes, S, Stafford, L, Johnson, S, Wootton, DG, Conlon, CP, Jeffery, K, Matthews, PC, Frater, J, Deeks, AS, Pollard, AJ, Brown, A, Rowland-Jones, SL, Mongkolsapaya, J, Barnes, E, Hopkins, S, Hall, V, Dold, C, Duncan, CJA, Richter, A, Carroll, M, Screaton, G, de Silva, TI, Turtle, L, Klenerman, P, Dunachie, S
Other Authors:	PITCH Consortium
Format:	Journal article
Language:	English
Published:	Cell Press 2021

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Similar Items